>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

ALGN +16.6%, WDC +8.8%, SYNA +7.6%, TRMB +7.3%, BJRI +7.2%, LPLA +6.8%, TRVG +6.1%, (increases full-year guidance after Expedia (EXPE) releases first quarter results), RBS +5.5%,SWN +5.3%, MOBL +4.5%, CERN +4.1%, ZEUS +4.1%, GOOG +4%,UBS +3.8%, AMZN +3.6%, HLS +3.4%, IDXX +3.4%, SMCI +2.9%,APO +2.9%, WETF +2.7%, MMSI +2.6%, HMC +2.6%, SNE +2.5%,RCL +2.5%, VDSI +2.2%, BRKS +2.2%, EHTH +2.2%, AVHI +2.1%,ASX +2.1%, VRTX +2%, GM +1.9%, TEAM +1.6%, AEM +1.6%, GT +1.6%, GLPG +1.5%, HST +1.4%, SNY +1.4%, XOM +1.4%, PSX +1.3%, MITK +1.2%, TRI +1.2%, PXLW +1.1%, ROP +1.1%, FHB +1%, MDXG +0.9%, SRPT +0.8%, GPRO +0.7%, .

Select metals/mining stocks trading higher:

SBGL +2.4%, CLF +2.4%, MT +2.3%, VALE +2%, AU +1.9%, GFI+1.8%, BBL +1.5%, AUY +1.5%, BHP +1.4%, RIO +1.3%, ABX+1.2%, GDX +0.9%, .

Other news:

PER +4.8% ( increases quarterly distribution to $0.13/unit from $0.12/unit)
BLDP +3.8% (signs a follow-on contract with an unnamed global automotive OEM for Technology Solutions)
HON +3.6% (higher on Third Point stake news; Honeywell responds to Third Point's investment thesis; intends to take the time necessary to ensure a comprehensive, informed and objective review of the potential separation of the Aerospace business)
DELT +3.1% (continued strength after closing near highs)
CEI +2.8% (cost-cutting initiatives to significantly reduce overall general and administrative costs)
STM +2.2% (in sympathy with WDC)
MU +2.1% (in sympathy with WDC)
FLXN +1.4% (presents results from two new analyses of its Zilretta for the treatment of osteoarthritis related knee pain)
RXDX +1.1% (announces program update on entrectinib; based on FDA feedback, co intends to pursue an NDA submission for entrectinib to support a TRK fusion-positive, tissue agnostic indication)
AMD +1% (in sympathy with WDC)

Analyst comments: